Journal Home
Access this journal onSciVerse ScienceDirect
Visit SciVerse ScienceDirect to see if you have access via your institution.
Search for
Advanced Search - MEDLINE - My Recent Searches - My Saved Searches - Search Tips
More periodicals:

Volume 5, Issue 1, Page 10 (January 2010)


View previous. 11 of 43 View next.

PREVIEW

FULL TEXT

FULL-TEXT PDF (83 KB)

CITATION ALERT

CITED BY

EXPORT CITATION

EMAIL TO A COLLEAGUE

RIGHTS/PERMISSIONS

DOWNLOAD IMAGES

NEED REPRINTS?

Once-Promising Arzoxifene Flunks Phase III Trial

BRUCE JANCIN

SAN ANTONIO — Arzoxifene, a once-promising selective estrogen-receptor modulator, experienced a fatal meltdown in a phase III trial involving nearly 10,000 women.

PII: S1558-0164(10)70011-0

doi:10.1016/S1558-0164(10)70011-0


View previous. 11 of 43 View next.

Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us |
The content on this site is intended for health professionals.